Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFα therapy
Hubert Marotte, Pierre MiossecClinical Immunology Unit, Departments of Immunology and Rheumatology, University of Lyon, and Unité Mixte Hospices Civils de Lyon–bioMérieux, Hôpital Edouard Herriot, Lyon, FranceAbstract: This review focuses on...
Guardado en:
Autores principales: | Hubert Marotte, Pierre Miossec |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f894966d3ecc46ec8226c9d102eb9061 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure
por: Kekow J, et al.
Publicado: (2012) -
Goals for rheumatoid arthritis: treating to target or treating to prevent?
por: Yang M, et al.
Publicado: (2012) -
Regression of macular edema secondary to branch retinal vein occlusion during anti-TNF-α therapy for rheumatoid arthritis
por: Shu Kachi, et al.
Publicado: (2010) -
BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors
por: Borja Hernández-Breijo, et al.
Publicado: (2021) -
Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis
por: Francesco Ursini, et al.
Publicado: (2017)